Anavex Life Sciences Corp (AVXL)

[JB3729]

No, not for this Anavex Plus application. Anavex tried to include protection for A2-73 in combo with other drugs and that didn't fly. I don't think that Anavex had done preclinical work on those other combos.

As makemydaze pointed out, Anavex's patent attorney and the examiner had a phone conversation on 7/27. On 8/1, Anavex submitted this -

Applicant agrees with the Examiner's Action that Fig. 5 demonstrates the synergy of A2-73 and donepezil.

Applicant believes that this application is in condition for allowance, which is respectfully requested.